We are live on
!
Find out more
Glenview Capital Management Portfolio holdings
AUM
$5.49B
Turnover
46.55%
1-Year Est. Return
46.89%
This Fund
S&P 500
This Quarter
Est. Return
+33.56%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$4.36B
AUM Growth
+$1.18B
(+37%)
Cap. Flow
+$134M
Cap. Flow
% of AUM
3.06%
Top 10 Holdings %
Top 10 Hldgs %
59.63%
Holding
58
New
13
Increased
19
Reduced
21
Closed
2
Avg Time Held Equity + Options
2
years
Top 10 Avg Time Held Equity + Options
1.7
years
Top 20 Avg Time Held Equity + Options
1.6
years
Avg Time Held Equity only
2.1
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$59.8M |
| 2 |
Elevance Health
ELV
|
+$56.6M |
| 3 |
Lyft
LYFT
|
+$50.4M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$41.3M |
| 5 |
Baxter International
BAX
|
+$33.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Paramount Global Class B
PARA
|
+$67.3M |
| 2 |
HCA Healthcare
HCA
|
+$49.5M |
| 3 |
Tenet Healthcare
THC
|
+$48.5M |
| 4 |
Hologic
HOLX
|
+$45.6M |
| 5 |
MTOR
MERITOR, Inc.
MTOR
|
+$29.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 69.55% |
| 2 | Technology | 11.97% |
| 3 | Materials | 5.01% |
| 4 | Consumer Discretionary | 4.95% |
| 5 | Industrials | 3.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Tenet Healthcare
THC
$22.2B
| $729M | 16.72% |
18,258,810
-1,502,543
| -8% | -$48.5M |
2013 Q2
30 quarters
|
|
2
Bausch Health
BHC
$2.36B
| $342M | 7.84% |
16,434,019
+1,476,311
| +10% | +$27.5M |
2018 Q3
9 quarters
|
|
3
Takeda Pharmaceutical
TAK
$62.2B
| $278M | 6.37% |
15,260,512
-1,528,077
| -9% | -$26.8M |
2019 Q1
7 quarters
|
|
4
DXC Technology
DXC
$2.2B
| $261M | 5.99% |
10,149,059
-69,156
| -0.7% | -$1.48M |
2017 Q2
14 quarters
|
|
5
Cigna
CI
$79B
| $261M | 5.99% |
1,255,021
-55,006
| -4% | -$10.8M |
2013 Q2
30 quarters
|
|
|
6
HCA Healthcare
HCA
$101B
| $214M | 4.9% |
1,300,181
-338,334
| -21% | -$49.5M |
2013 Q2
30 quarters
|
|
7
McKesson
MCK
$117B
| $203M | 4.66% |
1,167,689
-99,570
| -8% | -$16.6M |
2016 Q4
16 quarters
|
|
8
Labcorp
LH
$26.4B
| $112M | 2.58% |
642,746
-170,240
| -21% | -$29.4M |
2020 Q2
2 quarters
|
|
|
9
Lyft
LYFT
$6.5B
| $101M | 2.33% |
2,064,179
+1,385,227
| +204% | +$50.4M |
2020 Q2
2 quarters
|
|
|
NUAN
10
DELISTED
Nuance Communications, Inc.
NUAN
| $98.7M | 2.26% |
2,238,367
-167,900
| -7% | -$6.36M |
2018 Q3
9 quarters
|
|
|
11
Boston Scientific
BSX
$64B
| $97.2M | 2.23% |
2,702,881
+1,657,829
| +159% | +$59.8M |
2020 Q1
3 quarters
|
|
12
Universal Health Services
UHS
$11B
| $85.8M | 1.97% |
624,152
+48,518
| +8% | +$6.04M |
2016 Q3
17 quarters
|
|
13
Cencora
COR
$65.1B
| $85.6M | 1.96% |
875,442
+55,768
| +7% | +$5.58M |
2018 Q1
11 quarters
|
|
14
FMC
FMC
$874M
| $81.8M | 1.88% |
711,796
+17,287
| +2% | +$1.92M |
2015 Q1
23 quarters
|
|
15
Brookdale Senior Living
BKD
$2.41B
| $79.8M | 1.83% |
18,005,910
+5,419,356
| +43% | +$20M |
2014 Q2
26 quarters
|
|
|
MTOR
16
DELISTED
MERITOR, Inc.
MTOR
| $77M | 1.76% |
2,757,332
-1,113,959
| -29% | -$29.4M |
2013 Q2
30 quarters
|
|
17
Myriad Genetics
MYGN
$415M
| $72.8M | 1.67% |
3,682,691
+924,698
| +34% | +$14.9M |
2019 Q3
5 quarters
|
|
18
Element Solutions
ESI
$8.66B
| $68.6M | 1.57% |
3,866,712
+1,383,189
| +56% | +$19.1M |
2016 Q3
17 quarters
|
|
19
Humana
HUM
$51.9B
| $65.4M | 1.5% |
159,480
+76,391
| +92% | +$31.8M |
2018 Q4
8 quarters
|
|
20
Avis
CAR
$3.88B
| $64.3M | 1.47% |
1,724,413
+403,059
| +31% | +$14.2M |
2014 Q1
27 quarters
|
|
21
IQVIA
IQV
$44.6B
| $60.9M | 1.4% |
339,657
-79,328
| -19% | -$13.4M |
2016 Q2
18 quarters
|
|
|
22
Elevance Health
ELV
$92.9B
| $59.2M | 1.36% |
+184,461
| New | +$56.6M |
2020 Q4
0 quarters
|
|
|
23
DELISTED
Hologic
HOLX
| $58.6M | 1.34% |
804,442
-645,729
| -45% | -$45.6M |
2018 Q2
10 quarters
|
|
24
Expedia Group
EXPE
$35B
| $56.8M | 1.3% |
428,895
+83,462
| +24% | +$9.41M |
2020 Q2
2 quarters
|
|
25
Fiserv Inc
FISV
$25.1B
| $55.1M | 1.26% |
483,726
+289,811
| +149% | +$31.2M |
2019 Q3
5 quarters
|
|
Similar funds
MC
SCM
Glenview Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Glenview Capital Management held 58 positions worth $4.36B, up 37% from $3.19B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Glenview Capital Management deployed $134M of net new capital in Q4 2020, opening 13 new positions and adding to 19 existing holdings. Its largest new stake was Elevance Health: 184,461 shares worth $59.2M.
By sector, the portfolio is most concentrated in Healthcare at 70% of assets, down from 74% a quarter earlier, followed by Technology and Materials.
On the sell side, the largest reduction was Paramount Global Class B, an estimated $67.3M trimmed.
- Glenview Capital Management's largest Q4 2020 buy was Elevance Health: 184,461 shares worth $59.2M.
- Glenview Capital Management added most to Boston Scientific in Q4 2020, an estimated $59.8M increase.
- Glenview Capital Management's biggest Q4 2020 reduction was Paramount Global Class B, cutting an estimated $67.3M.
- Glenview Capital Management fully exited eBay in Q4 2020, selling an estimated $15.1M.
- Glenview Capital Management's ten largest holdings make up 60% of its $4.36B portfolio in Q4 2020.
- Glenview Capital Management opened 13 new positions and closed 2 in Q4 2020.
- Glenview Capital Management's portfolio value rose 37% quarter-over-quarter to $4.36B.
Based on Glenview Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.